Psoriatic arthritis (PsA) is a chronic autoimmune disorder that affects the joints and skin. It is a type of inflammatory arthritis that is associated with psoriasis, a common skin condition. PsA is a complex condition that can be difficult to diagnose and manage. This article aims to provide an overview of PsA and discuss current treatment and management strategies.
Psoriatic arthritis is a form of inflammatory arthritis that affects the joints and skin. It is an autoimmune disorder, meaning that the body’s immune system mistakenly attacks healthy cells and tissues. In PsA, the immune system attacks the joints and skin, leading to inflammation and pain. PsA is closely associated with psoriasis, a common skin condition. Approximately 30% of people with psoriasis also develop PsA. The two conditions often occur together, and symptoms of PsA often appear before or at the same time as psoriasis.
The symptoms of PsA vary from person to person, and can range from mild to severe. Common symptoms include: • Joint pain, stiffness, and swelling • Fatigue • Tenderness in the joints • Swelling of the fingers and toes • Nail changes, such as pitting or discoloration • Skin changes, such as redness or scaling
The diagnosis of PsA can be difficult, as the symptoms can be similar to other types of arthritis. To diagnose PsA, a doctor will take a detailed medical history, perform a physical exam, and order blood tests and imaging tests. The doctor may also refer the patient to a rheumatologist, a doctor who specializes in treating arthritis and autoimmune disorders. The rheumatologist can help to confirm the diagnosis and develop a treatment plan.
The goal of treatment for PsA is to reduce inflammation and pain, and improve function and quality of life. Treatment options include: • Non-steroidal anti-inflammatory drugs (NSAIDs): These medications can help to reduce pain and inflammation. • Disease-modifying antirheumatic drugs (DMARDs): These medications can help to slow the progression of the disease and reduce inflammation. • Biologic agents: These medications target specific parts of the immune system to reduce inflammation and slow the progression of the disease. • Corticosteroids: These medications can help to reduce inflammation and pain. • Physical therapy: Physical therapy can help to improve joint function and reduce pain.
In addition to medications, lifestyle changes can also help to manage PsA. These include: • Regular exercise: Exercise can help to reduce pain and stiffness, and improve joint function. • Stress reduction: Stress can worsen the symptoms of PsA, so it is important to find ways to manage stress. • Healthy diet: Eating a healthy diet can help to reduce inflammation and improve overall health. • Weight management: Being overweight can worsen the symptoms of PsA, so it is important to maintain a healthy weight.
Psoriatic arthritis is a complex condition that can be difficult to diagnose and manage. Treatment and management strategies include medications, physical therapy, and lifestyle changes. By understanding the symptoms and treatment options, people with PsA can work with their healthcare team to find the best treatment plan for their individual needs.
1.
Breast cancer patients' arms swell less after an effective lymph node transfer.
2.
Is Laughter Good for Blood Glucose Control?
3.
Congresswoman has cancer; the IRS is suing a controversial doctor; and caffeine and teenagers.
4.
MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC
5.
On all CAR-T products, the FDA is calling for a new boxed warning.
1.
Optimizing the Diagnosis and Treatment of Hematological Diseases Through Artificial Intelligence
2.
Preventing Heparin Induced Thrombocytopenia: Tips for Successful Anticoagulation Therapy
3.
The Latest Research on Acute Promyelocytic Leukemia: Advancements in Diagnosis and Therapy
4.
Unraveling the Mysteries of Coagulopathy: A Comprehensive Definition
5.
Immunotherapy Breakthroughs: Transforming Cancer Care Across All Oncology Fields
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
2.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II
4.
Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation